The FDA clearance of Spectrum Dynamics' Veritas.AI platform marks a significant step forward for nuclear imaging, promising to cut scan times in half and enhance image clarity for critical applications like cancer theranostics.
Lloyds Banking Group has unveiled a significant capital return to shareholders, launching a £1.75 billion share buyback and raising its dividend by 15%. The move follows robust full-year results and digital progress, but unfolds against a backdrop of ongoing regulatory scrutiny and strategic reinvestment needs.
As Verizon Communications navigates a $29 million ESOP share registration and heightened regulatory scrutiny of its $20 billion Frontier fiber acquisition, analysts are increasingly framing the telecom giant as a high-yield, bond-proxy utility. With heavy debt and dividend commitments constraining flexibility, the company's strategic moves are being watched for signs of how it will balance growth with its new, more regulated profile.
A new Fox News survey reveals Democrats leading Republicans 52% to 46% in a generic congressional ballot for the 2026 midterms, the highest level of support recorded for either party in this poll series. Voter priorities and sharp partisan divides on key issues shape the early political landscape.
While Morgan Stanley maintains an Overweight rating on PDD Holdings, the firm has removed the e-commerce giant from its Top Picks list, citing heightened regulatory scrutiny and a slower-than-expected consumer recovery in China.
Sanofi reports a pivotal Phase 3 win for its investigational therapy venglustat in a rare neurological disorder, alongside positive EU regulatory news for Rezurock and progress for amlitelimab, signaling a strategic shift toward high-value specialty medicines.
The U.S. Food and Drug Administration has issued a complete response letter for Aquestive Therapeutics' oral film drug designed to treat severe allergic reactions, the company announced Monday, delaying a potential new option for millions at risk.
Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...
Spanish healthtech startup Biorce has closed a substantial Series A round, backed by prominent venture capital and angel investors, to scale its AI-driven clinical trial solution, Aika, internationally amid a tightening regulatory landscape.
Wells Fargo's board has approved a 28% compensation increase for CEO Charlie Scharf, bringing his total package to $40 million for the past year. The move comes as the bank marks a pivotal turnaround, with major federal penalties lifted and its transformation under Scharf's leadership cited as justification for the raise.
Facing pressure from both investors and regulators, banks and wealth managers are turning to pass-through voting mechanisms to reclaim shareholder influence and align stewardship with client values, even within passively managed funds.
The European CE Mark under the stringent MDR has been granted for Cynosure Lutronic's innovative fractional resurfacing system, designed to improve safety and patient comfort through advanced cooling and precision technology.
French IT giant Capgemini initiates the sale of its U.S. federal subsidiary, Capgemini Government Solutions, attributing the move to restrictive oversight rules for classified contracts and a desire for strategic focus.
Despite recent price pressures, Ethereum is positioned for a potential surge, driven by impending U.S. crypto legislation and its dominant role in the booming tokenization of real-world assets. Analysts see a pivotal window opening before mid-2026.
A Nevada court has issued a temporary restraining order against prediction market platform Polymarket, blocking it from offering event contracts to state residents. The ruling marks a significant early victory for state gaming regulators amid a national debate over who should oversee these fast-growing markets.
Senator John Fetterman (D-PA) denounced activists seeking to expose the personal information of immigration enforcement personnel, calling the practice dangerous and unacceptable during a Sunday television appearance.
The Hong Kong Monetary Authority has detailed its enhanced oversight framework for key retail payment systems, designating networks like Visa, Mastercard, and UnionPay for direct supervision to ensure security and stability in the city's rapidly digitizing economy.
GameStop's stock jumped nearly 5% Friday after the company announced plans for a billion-dollar acquisition, described by CEO Ryan Cohen as a potentially 'transformational' move for the retailer and the markets.
Facing a significant stock decline and a challenging Medicare Advantage outlook, UnitedHealth Group announces leadership changes and a 'Back to Basics' operational reset, aiming to stabilize its core business amid shifting market dynamics.
Venture capital titans Marc Andreessen and Ben Horowitz lead a massive $50.8 million fundraising effort for a new super PAC, 'Leading the Future,' aiming to shape AI-friendly policies in the 2026 elections.
